Vontobel Holding
PDSB icon

Vontobel Holding’s PDS Biotechnology PDSB Stock Holding History

Vontobel Holding’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,000
Closed -$65.2K – 1141
2024
Q4 		$65.2K Hold
40,000
– – ﹤0.01% 1058
2024
Q3 		$153K Buy
40,000
+28,000
+233% +$93.4K ﹤0.01% 1018
2024
Q2 		$35.2K Sell
12,000
-20,000
-63% -$64K ﹤0.01% 1055
2024
Q1 		$127K Sell
32,000
-9,000
-22% -$46.4K ﹤0.01% 1014
2023
Q4 		$204K Hold
41,000
– – ﹤0.01% 1012
2023
Q3 		$207K Buy
41,000
+9,000
+28% +$49.3K ﹤0.01% 978
2023
Q2 		$161K Buy
32,000
+19,000
+146% +$124K ﹤0.01% 1023
2023
Q1 		$80K Buy
+13,000
New +$106K ﹤0.01% 1032

Other funds holding PDSB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Vontobel Holding's PDSB Position: Q1 2025 in Review

Vontobel Holding sold out of PDS Biotechnology (PDSB) in Q1 2025, closing a stake of 40,000 shares — an estimated $65.2K sold.

Vontobel Holding first reported a position in PDSB in Q1 2023 and held it in 8 quarters. The position peaked at $207K in Q3 2023. 48 funds tracked by Wall St. Rank hold PDSB as of Q1 2025.

  • Vontobel Holding reported no remaining PDS Biotechnology position as of Q1 2025 after selling out during the quarter.
  • Vontobel Holding sold 40,000 PDS Biotechnology shares in Q1 2025, an estimated $65.2K.
  • Vontobel Holding first reported a position in PDS Biotechnology in Q1 2023 and held it in 8 quarters.
  • Vontobel Holding's PDS Biotechnology position peaked at $207K in Q3 2023.
  • 48 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2025.

Based on Vontobel Holding's 13F filing for Q1 2025, filed 28 Apr 2025.